Get startedLog in
    Picture of BLS Pharmaceuticals logo

    BXNDA — BLS Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Brief: Bioxyne Posts HY Loss Attributable A$12.3 Million

    Picture of BLS Pharmaceuticals logoBLS Pharmaceuticals
    29/02/2024 02:03
    Feb 29 (Reuters) - Bioxyne Ltd  BXN.AX :
    * HY  LOSS ATTRIBUTABLE A$12.3 MILLION VERSUS LOSS A$818,424
    * HY REVENUES FROM CONTINUING OPERATIONS A$4.9 MILLION
VERSUS
A$2.4 MILLION

Source text for Eikon:  ID:nASX66P4xz 
Further company coverage:  BXN.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on BLS Pharmaceuticals

    See all news